Occam partners with organizations in the life sciences, technology, and investment sectors to recruit C-Suite executives across both the commercial and R&D functions.
Biotech firm Beam Therapeutics is pioneering the use of CRISPR base editing techniques that enable the permanent rewriting of single letters in the human genome.View Case
Chiasma is a public, clinical-stage biopharmaceutical company focused on improving the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases.View Case
Elicio Therapeutics is committed to transforming the lives of patients by re-engineering the body’s immune response to defeat cancer.View Case
Semma Therapeutics is pioneering the new treatment paradigm of using cells as medicine.View Case